National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
F32GM097888
米国
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
R01GM050291
米国
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
R35GM130398
米国
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
T32GM008281-28
米国
National Institutes of Health/National Center for Research Resources (NIH/NCRR)
S10RR026540
米国
National Institutes of Health/Office of the Director
S10OD016432
米国
引用
ジャーナル: Cell Rep / 年: 2021 タイトル: Asterix/Gtsf1 links tRNAs and piRNA silencing of retrotransposons. 著者: Jonathan J Ipsaro / Paul A O'Brien / Shibani Bhattacharya / Arthur G Palmer / Leemor Joshua-Tor / 要旨: The Piwi-interacting RNA (piRNA) pathway safeguards genomic integrity by silencing transposable elements (transposons) in the germline. While Piwi is the central piRNA factor, others including ...The Piwi-interacting RNA (piRNA) pathway safeguards genomic integrity by silencing transposable elements (transposons) in the germline. While Piwi is the central piRNA factor, others including Asterix/Gtsf1 have also been demonstrated to be critical for effective silencing. Here, using enhanced crosslinking and immunoprecipitation (eCLIP) with a custom informatic pipeline, we show that Asterix/Gtsf1 specifically binds tRNAs in cellular contexts. We determined the structure of mouse Gtsf1 by NMR spectroscopy and identified the RNA-binding interface on the protein's first zinc finger, which was corroborated by biochemical analysis as well as cryo-EM structures of Gtsf1 in complex with co-purifying tRNA. Consistent with the known dependence of long terminal repeat (LTR) retrotransposons on tRNA primers, we demonstrate that LTR retrotransposons are, in fact, preferentially de-repressed in Asterix mutants. Together, these findings link Asterix/Gtsf1, tRNAs, and LTR retrotransposon silencing and suggest that Asterix exploits tRNA dependence to identify transposon transcripts and promote piRNA silencing.
分子量: 65.409 Da / 分子数: 2 / 由来タイプ: 合成 / 式: Zn / タイプ: SUBJECT OF INVESTIGATION
研究の焦点であるリガンドがあるか
Y
-
実験情報
-
実験
実験
手法: 溶液NMR
NMR実験
Conditions-ID
Experiment-ID
Solution-ID
Sample state
Spectrometer-ID
タイプ
1
1
1
isotropic
7
2D 1H-15N HSQC
1
2
3
isotropic
7
2D 1H-13C HSQC
1
3
2
isotropic
5
3D HNCA
1
4
2
isotropic
9
3DHN(CO)CA
1
5
2
isotropic
9
3D HNCO
1
6
2
isotropic
7
3DHN(CA)CO
1
7
2
isotropic
7
3D HN(CA)CB
1
8
2
isotropic
9
3DHN(COCA)CB
1
9
2
isotropic
7
3D (H)CCH-TOCSY
1
10
2
isotropic
6
3DHBHA(CO)NH
1
11
2
isotropic
6
3DH(CCO)NH
1
12
2
isotropic
6
3D (H)C(CCO)NH
1
13
1
isotropic
7
3D 1H-15N NOESY
1
14
3
isotropic
7
3D 1H-13C NOESY
1
15
3
isotropic
7
3D 1H-13C NOESY aromatic
-
試料調製
詳細
タイプ
Solution-ID
内容
Label
溶媒系
solution
1
0.5 mM [U-15N] Gtsf1, 90% H2O/10% D2O
15N_sample
90% H2O/10% D2O
solution
2
0.8 mM [U-13C; U-15N] Gtsf1, 90% H2O/10% D2O
13C_15N_sample
90% H2O/10% D2O
solution
3
0.8 mM [U-13C; U-15N] Gtsf1, 100% D2O
13C_15N_D2O_sample
100% D2O
試料
濃度 (mg/ml)
構成要素
Isotopic labeling
Solution-ID
0.5mM
Gtsf1
[U-15N]
1
0.8mM
Gtsf1
[U-13C; U-15N]
2
0.8mM
Gtsf1
[U-13C; U-15N]
3
試料状態
詳細: Buffer composition was 50 mM MES, pH 6.5, 200 mM NaCl, 5 mM TCEP, 2:1 stoichiometric ZnCl2, 4:1 stoichiometric MgCl2, and 0.02% azide. 0.1 mM DSS was included in samples for internal ...詳細: Buffer composition was 50 mM MES, pH 6.5, 200 mM NaCl, 5 mM TCEP, 2:1 stoichiometric ZnCl2, 4:1 stoichiometric MgCl2, and 0.02% azide. 0.1 mM DSS was included in samples for internal referencing of 1H chemical shifts. イオン強度: 200 mM NaCl mM / Label: conditions / pH: 6.5 / 圧: 1 atm / 温度: 298 K